Friday, April 14, 2017

Why did a negative article about PLX outweigh positive phase ii results?

Recently Protalix Therapeutics released the data for their phase ii clinical trial of their Cystic Fybrosis drug which were psoitive and and atleast 2 points better than any other drug on the market. Yet 2 hours after this data came out Adam Ferenza released an article bashing plx which subsequently led to the stock crashing. Why is this the case?



Submitted April 14, 2017 at 10:43AM by jameswoodshighschool http://ift.tt/2peQ5eJ

No comments:

Post a Comment